Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy

Ann Surg Oncol. 2023 Jun;30(6):3194-3196. doi: 10.1245/s10434-023-13318-5. Epub 2023 Mar 14.

Authors

Austin M Eckhoff¹, Elishama Kanu¹, Matthew Bao¹, Dan G Blazer 3rd¹, Sabino Zani¹, Michael E Lidsky¹, Peter J Allen¹, Daniel P Nussbaum²

Affiliations

¹ Department of Surgery, Duke University, Durham, NC, USA.
² Department of Surgery, Duke University, Durham, NC, USA. daniel.nussbaum@duke.edu.

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Carcinoma, Pancreatic Ductal* / secondary
Humans
Pancreatic Neoplasms* / diagnostic imaging
Pancreatic Neoplasms* / drug therapy
Retrospective Studies

Grants and funding